Pharmacy and Therapeutics Committees in Thai Hospitals under Health Reform Sripairoj A, Liamputtong P, Harvey K La Trobe University, Australia.

Slides:



Advertisements
Similar presentations
Board Governance: A Key to Quality Organizations
Advertisements

[Imagine School at North Port] Oral Exit Report Quality Assurance Review Team School Accreditation.
Common/shared responsibilities between jobs.
Medication Management
Quality Improvement/ Quality Assurance Amelia Broussard, PhD, RN, MPH Christopher Gibbs, JD, MPH.
December 6, Exploring the Role of a PAC By the AB SpEd PAC.
NATIONAL EVALUATION OF MEDICINES DISPENSING WITHIN BRAZILIAN AIDS PROGRAM Third International Conference for Improving Use of Medicines Azeredo TB, Luiza.
PHAB's Approach to Internal and External Evaluation Jessica Kronstadt | Director of Research and Evaluation | November 18, 2014 APHA 2014 Annual Meeting.
Quality Improvement Prepeared By Dr: Manal Moussa.
Quality assurance in IVET in Romania Lucian Voinea Mihai Iacob Otilia Apostu 4 th Project Meeting Prague, 21 st -22 nd October 2010.
State of Maine: Quality Management and National Core Indicators.
Atlanta Public Schools Principal Selection Process Human Resources, Center of Expertise Updated March 3, 2014.
Review of progress in implementing tasks assigned, impediments to implementation and solutions.
Spain. Learnings from yesterday Global approach: all diseases and all clinical settings rather than focusing on particular diseases Institutional leadership.
The New Role and New Mission of Cooperative Auditing Department in Thailand. Assist. Prof. Dr. Ratana Pothisuwan Assoc. Prof. Dr. Prasert Janyasupab Department.
Problem Statement: In Kenya, despite the development of national standard treatment guidelines (STGs) for the management of acute respiratory infections.
University of Idaho Successful External Program Review Archie George, Director Institutional Research and Assessment Jane Baillargeon, Assistant Director.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
External Review Exit Report Anderson School District 4 November , 2014.
ABSTRACT Title: Developing National Formularies Based on the WHO Model Formulary Authors: Tisocki K 3, Laing RL 1, Hogerzeil H 1, Mehta DK 2, Ryan RSM.
AdvancED District Accreditation Process © 2010 AdvancED.
Building and Recognizing Quality School Systems DISTRICT ACCREDITATION © 2010 AdvancED.
THE NUTS AND BOLTS OF ADVISORY COMMITTEES Development of Work-Based Learning Programs Unit 6-- Developing and Maintaining Community and Business Partnerships.
Brian McDonough, MD CMIO: St. Francis Hospital Chairman: CHE Pharmacy and Therapeutics Committee.
Abstract ID: 395 Author Name: Araya Sripairoj Presenter Name: Araya Sripairoj Authors: Sripairoj A, Liamputtong P, Harvey K.
CHAPTER V Health Information. Updates on new legislation (1)  Decision No.1605/2010/QĐ-TTg approving the National Program for Application of information.
An Intervention To Improve Antibiotic Prescribing Habits of Doctors in a Teaching Hospital Ofei F, Forson A, Tetteh R, Ofori-Adjei D University of Ghana.
MEDICAL SERVICE ADMINISTRATION VIETNAM MINISTRY OF HEALTH
Budget Formulation 2017/2018 A review of the 2017 process and the 2018 process. Office of Budget and Performance Management November 2015.
External Review Team: Roles and Responsibilities A Very Brief Training! conducted by JoLynn Noe Office of Assessment.
Unit 9: Evaluating a Public Health Surveillance System #1-9-1.
External Review Exit Report Towns County School System October 4-7, 2015.
DOES DRUG USE EVALUATION (DUE) REQUIRED BY NATIONAL POLICY IMPROVE USE OF MEDICINES?
Establishing Effective Hospital Drug and Therapeutics Committees: a situational analysis Ndhlovu C E, Simoyi T National Drug and Therapeutics Policy Advisory.
Does Drug Use Evaluation Required by National Policy Improve Use of Medicines? Akaleephan C*, Muenpa R**, Sittitanyakit B***, Treesak C #, Cheawchanwattana.
CHB Conference 2007 Planning for and Promoting Healthy Communities Roles and Responsibilities of Community Health Boards Presented by Carla Anglehart Director,
Project: EaP countries cooperation for promoting quality assurance in higher education Maria Stratan European Institute for Political Studies of Moldova.
Huntsville City Schools AdvancEd Survey District Accreditation Cathy C. McNeal, Ed.D. January 8, 2013.
Impact of Currency Crisis on Availability, Affordability, and Use of Medicines in Indonesia: A 5-Year Longitudinal Study Sri Suryawati Center for Clinical.
ROLES AND RESPONSIBILITIES OF TFDA ON ADDO PROGRAM
Clinical Learning Environment Review GMEC January 8, 2013
Session VI: Communication Plan
Patient Involvement in the HTA Decision Making Process
International Conference on Improving Use of Medicines
BUILDING THE NATIONAL DRUG POLICY ON EVIDENCE: ASSESSING IMPLEMENTATION IN LAO PDR Paphassarang C1, Wahlström R2, Phoummalaysith B3,
Community Participation in Research
ROLES AND RESPONSIBILITIES OF VARIOUS LEVELS IN ESTABLISHING AND IMPLEMENTING THE ADDO PROGRAM August 2009.
ABSTRACT THE IMPACT OF CONTINUOUS MEDICAL EDUCATION ON PRESCRIBING
Evaluating and improving a clinical practice guideline in the Western Cape, South Africa AIM STATEMENT: To design and use an appropriate evaluation tool.
SUNARTONO HEAD OF SLEMAN DISTRICT HEALTH OFFICE, INDONESIA
ABSTRACT Problem statement: The Lao PDR National Drug Policy (NDP) Program, implemented by the Ministry of Health supported by the Swedish International.
GIFT and IBP Pilot PROJECT on PUBLIC PARTICIPATION
HIV Quality Improvement (QI) and the Treatment Cascade: How QI has Impacted Reach, Recruitment, Testing, Treatment, and Retention Efforts in Thailand?
Abstract Impact of the National Healthcare Reform on Prescribing Patterns of Promotional Targeted Drugs among Thai Physicians Layton MR*, Chadbunchachai.
DISTRICT ACCREDITATION QUALITY ASSURANCE REVIEW
Introduction to the training
MULTI-CENTER INDICATOR INTERVENTION RESEARCH ON SURGICAL PHROPHYLAXIS IN 2 HOSPITALS OF
Role of Academic Services
ABSTRACT   Qualitative and Quantitative Assessment of the Essential Medicines List of Delhi State: A Time Series Analysis. Gupta U, Sangeeta S, Baishya.
Health and Social Services in the Department of Health
Supporting SEACs across the Province:
PRESENTATION OF EXISTING EVALUATION
Auditing Compliance with the Privacy Rule
Strategic Planning.
Khayelitsha District Hospital Investigation
By: Andi Indahwaty Sidin A Critical Review of The Role of Clinical Governance in Health Care and its Potential Application in Indonesia.
Gauteng Provincial Legislature Money Bills Act Discussion
FROM SUPERVISION TO INNOVATION The Basque Inspectorate of Education experience BASQUE INSPECTORATE OF EDUCATION. MADEIRA, May 2019.
A pathway to policy commitment for sustainability of a key population-led health services model in Thailand Dr. Preecha Prempree Deputy Director-General,
Dr. Robert Perry, Dr. Mick Arnold,
Presentation transcript:

Pharmacy and Therapeutics Committees in Thai Hospitals under Health Reform Sripairoj A, Liamputtong P, Harvey K La Trobe University, Australia

Outline of presentation Background Objectives Methods and Samples Results Summary Conclusion and Policy Implications

Background In Thailand, hospitals under the Office of the Permanent Secretary were first required to establish Pharmacy and Therapeutics Committees (PTCs) in 1987. A Manual of Drug Administration (1987) listed the expected structure, roles and responsibilities of PTCs. Since 1997, Thai hospitals have faced economic crisis, quality improvement and accreditation, universal coverage health reform and structural change in the Ministry of Public Health (MoPH).

Objectives To examine PTC performance during this period of change and reform. To determine the opinion of the PTC Chairpersons and the PTC Secretaries about defining good PTC performance, ways to improving PTC performance, and possible PTC performance indicators. To create a Manual that provides more practical help on rational drug use activities, including performance indicators.

Methods Retrospective document review In-depth interviews Questionnaire survey A focus group Participant observation

Sample & methods Seventeen hospitals (2 regional hospitals, 3 provincial hospitals, and 12 district hospitals) in 4 regions of Thailand. Ten key informants who were the Chairperson, the Secretary or members of the PTC were interviewed. Fifteen key informants who involved with PTC or who are responsible for drug information centers were interviewed. Questionnaires were distributed to 452 PTC Chairpersons and Secretaries respectively in 25 regional hospitals, 67 provincial hospitals and 360 district hospitals. Eight key participants who were PTC stakeholders participated in a focus group. PTCs in 3 regional hospitals were observed.

Questionnaire results (1) The questionnaire response rate was 36% from PTC Chairpersons and 66% from Secretaries. Around 90% of PTC Chairpersons were Hospital Directors and 90% of Secretaries were Heads of Pharmacy Department. The average of the number of PTC members in regional, provincial and district hospitals was 19, 20, and 10 members, respectively. There were only 2-3 PTC meetings in regional or provincial hospitals and only 1-2 PTC meetings in district hospitals during each fiscal year (from 1996-2002).

Questionnaire results (2) The most important PTC performance indicators suggested by all PTC Chairpersons: Is PTC responsible for considering and approving allocation of drug budget proposed by the Pharmacy section? Does PTC have a document providing criteria for addition and deletion of drug in the hospital drug list? Does PTC have a policy to develop or implement Clinical Practice Guidelines for common problems such as acute respiratory infection, diarrheal diseases, hypertension, diabetes, epilepsy, and antibiotic prophylaxis, etc.? Does the PTC monitor Pharmacy drug dispensing to ensure it follows written standards of pharmacy professional practice? Does PTC conduct satisfaction surveys on hospital staff to receive feedback on PTC performance?

Questionnaire results (3) The most important PTC performance indicators suggested by PTC Secretaries: Does a document identifying goal, committee, objectives, and functions of PTC exists? Is PTC authorised to select drugs to be included and excluded in the hospital drug list? Does PTC monitor the percentage of drugs used outside hospital drug list? Does the PTC monitor Pharmacy drug dispensing to ensure it follows written standards of pharmacy professional practice? Does PTC have a policy to conduct satisfaction of patients/clients on the hospital treatment service?

Questionnaire results (4) When asked about the most important factor needed for the development of an effective PTC: the Chairpersons said it was an effective PTC Secretary; while the Secretaries said it was an effective PTC Chairperson. When asked about external factors that can contribute to improved performance of PTC both PTC Chairpersons and Secretaries in all hospitals agreed that the most important aspect was: a national collaborative drug information center as a hub for information exchange between PTC for a decision making purpose. In addition, PTC Chairpersons and PTC Secretaries in regional hospitals noted that: defining the function of PTC in the hospital accreditation criteria would be helpful.

Results (5) The retrospective document review, in-depth interviews, a focus group and participant observation noted that: Under new structure of Ministry of Public Health, there was no distinctive responsible organization who support and monitor PTCs. Some hospitals had not updated information about new PTC members, functions or responsibilities. Most PTC activities still focused on drug selection and controlling drug budget. Activities on rational drug use were few. Many PTCs had not set their own specific goals, objectives, role and responsibilities. Often PTCs had no working plan and there was also no orientation about goal, objectives, role and responsibilities for PTC members.

Results (6) Many suggested the need for a responsible organization (perhaps under the Department of Health Service Support) that would assist PTCs by: Updating Manual of PTC roles and responsibilities; Providing opportunities for PTC networking e.g. by web site &/or E-mail discussion groups; Providing information for PTC to make decisions; Supporting the incorporation of PTC performance indicators in hospital accreditation (Bureau of Inspection & Evaluation &/or The Institute of Hospital Quality Improvement& Accreditation); Encouraging Universities to provide educational programs.

Summary PTCs at all levels of hospital focused their activities on drug selection and budget as this was the main focus of the 1987 “Manual”. There were limited numbers of meetings of PTCs (1-2 in district hospitals; 2-3 in regional or provincial hospitals). The recommended PTC performance indicators were the number of PTC meetings and the number of drug items in hospital drug lists. Suggestions for improving PTC performance: Setting a responsible organization; Encouraging educational programs in universities; and Providing national drug information center and PTC networking.

Conclusion & Policy Implications There is a need for a responsible organization (perhaps under the Department of Health Service Support) that would assist PTCs by: Updating a Manual regarding PTC roles and responsibilities; Providing opportunities for PTC networking e.g. by web site &/or E-mail discussion groups; Providing information for PTC to make decisions; Supporting the incorporation of PTC performance indicators in hospital accreditation monitored by: Bureau of Inspection & Evaluation &/or The Institute of Hospital Quality Improvement & Accreditation; Encouraging Universities to provide PTC educational programs.

“We cannot direct the wind but we can adjust the sail.” “Learning to live, living to learn and have fun on improving Pharmacy and Therapeutics Committee performance.”